May 3, 2011
/PRNewswire/ -- GenVec, Inc. (Nasdaq: GNVCD) announced that it will release financial results for the first quarter ended
March 31, 2011
Monday, May 9, 2011
after market close. GenVec will hold a conference call at
10:00 a.m. EDT
Tuesday, May 10, 2011
to discuss the company's first quarter financial results and business outlook.
To listen to the live conference call, please dial 877-558-0567 (U.S. or
) or 706-643-4980 (international) and use the following Conference ID: 63890121. An audio replay of the conference call will be available starting at
1:00 p.m. EDT
May 10, 2011
May 17, 2011
. To listen to the audio replay, dial 800-642-1687 or 706-645-9291 and use Conference Replay ID: 63890121.
A live webcast of the conference call will be available on the Company's website and will be archived for 30 days. To access the webcast or the replay, go to
, click on "Investor Relations," and click on "Webcasts and Data."
GenVec, Inc. is a biopharmaceutical company using superior, proprietary technology to create differentiated vaccines and therapeutics that are developed and commercialized through collaborations. GenVec is working with leading companies and organizations such as Novartis, Merial, and the US Government to support a portfolio of product programs that address the prevention and treatment of a number of significant human and animal health concerns. GenVec's development programs address therapeutic areas such as hearing loss, balance disorders, and cancer; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), HSV-2, dengue fever, influenza, HIV, malaria, and foot-and-mouth disease. Additional information about GenVec is available at
and in the Company's various filings with the Securities and Exchange Commission.
Investor and Media Contact:
Douglas J. Swirsky
SOURCE GenVec, Inc.